When was Menarini Diagnostics founded?

Menarini Diagnostics was founded in 1976.

Where is Menarini Diagnostics located?

Menarini Diagnostics is headquartered in Florence, Italy.

How many employees does Menarini Diagnostics have?

As of May 31, 2026, the latest employee count at Menarini Diagnostics is 476.

Is Menarini Diagnostics a funded company?

Menarini Diagnostics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Menarini Diagnostics rank among its competitors?

Menarini Diagnostics ranks 239th amongst 2026 active competitors, of which 118 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Roche, which secured an undisclosed amount in May, 2023.

Who are the top competitors of Menarini Diagnostics?

Menarini Diagnostics' top competitors include Boston Scientific, Abbott and Medtronic. Among them, Roche secured the most recent funding round in May, 2023.

Menarini Diagnostics - 2026 Company Profile & Competitors

Menarini Diagnostics is an unfunded company based in Florence (Italy), founded in 1976. It operates as an Analyzer and reagents for Labs and POC testing. Menarini Diagnostics has not raised any funding yet. The company has 2026 active competitors, including 118 funded and 150 that have exited. Its top competitors include companies like Boston Scientific, Abbott and Medtronic.

Company Details

Menarini Diagnostics (part of Menarini Pharmaceutical Group) is focused on development and marketing of clinical diagnostic products. The company offers diagnostic products in the area of Diabetes (self-testing, POCT and laboratory systems), Biochemistry, electrolyte analyser (laboratory and POCT), automated cell counter, Urinalysis, Urine Sediment analysis, Hematology (Erythrocyte sedimentation rate, Hematology Cell Counters) Autoimmunity (Microplate and slide processor, automated immunoassay analyzer, microdot arrays for a panel of Autoimmune Diseases), Molecular Biology, CellPathology & Cytology and an Open Platform for POCT connectivity. In addition, the company offers HPLC analyzer for HbA1c and hemoglobinopathies, Hemoglobin analyzers and Mobile Centrifugal micro-technology (μTAS) single drop analyzer (HbA1c, CRP, and hsCRP). The company's main focus is on Continous Glucose Monitoring (GlucoDay® / GlucoMen® Day system)- it is a glucose holter which is able to continuously monitor the glucose concentration for a period up to 5 days using the micro-dialysis technology via a subcutaneous microfibre. The system has been CE-MD marked by the TÜV Product Service notify body.

Website: menarinidiagnostics.com/en.html
Part Of

Key Metrics

Founded Year

1976

Location

Florence, Italy

Stage

Unfunded

Ranked

239^th among 2026 active competitors

Employee Count

476 as on May 31, 2026

Similar Companies

Boston Scientific & 1980 more

View Menarini Diagnostics' full profile

Menarini Diagnostics has not raised any funding rounds yet.

Menarini Diagnostics' employee count trend

Menarini Diagnostics has 476 employees as of May 26. Here is Menarini Diagnostics's employee count trend over the years:

Employee count trend for Menarini Diagnostics

Uncover Menarini Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Menarini Diagnostics include Boston Scientific, Abbott and Medtronic. Here is the list of Top 10 competitors of Menarini Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Boston Scientific 1979, Marlborough (United States), Public	Wide range of medical devices	-	JANA Partners, Endeavour Vision & 10 others	81/100
2nd	Abbott 1888, Libertyville (United States), Public	Developer of medical devices, generic pharmaceuticals, and nutrition products	-	MSN Laboratories, Digital Pharma Lab & 12 others	80/100
3rd	Medtronic 1949, Minneapolis (United States), Public	Developer of medical equipment for chronic diseases	-	Saints Capital, Greyrock Investments & 27 others	80/100
4th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, Triodos Investment Management ... & 11 others	70/100
5th	Danaher 1969, Washington, DC (United States), Public	R&D company focused on manufacturing dental equipment for multiple therapeutic areas	-	Ventana Capital Management, Bank of America	69/100
6th	Baxter 1931, Deerfield (United States), Acquired	Provides biosciences, medication delivery and renal products	-	Triodos Investment Management, Tekla Capital Management ... & 7 others	68/100
7th	Trivitron 1997, Chennai (India), Series C	Provider of medical technology and devices for healthcare industry needs	$109M	Fidelity Investments, True North & 21 others	68/100
8th	Stryker 1941, Kalamazoo (United States), Acquired	Manufacturer of 3D-printed orthopedic products	-	Gefinor Capital, Castle Investment Management ... & 6 others	66/100
9th	SAGE Therapeutics 1971, Boston (United States), Acquired	Developer of drug candidates for the treatment of rare CNS disorders	$106M	Foresite Capital, Orbimed & 12 others	66/100
10th	HOYA 1941, Shinjuku (Japan), Public	Developer of a wide range of medical devices	-	-	65/100
239th	Menarini Diagnostics 1976, Florence (Italy), Unfunded	Analyzer and reagents for Labs and POC testing	-	-	28/100